Ambuja Cements Ltd

(AMBUJACEM)

Ambuja Cements Faces Sharp Decline Amid Bribery Allegations - 21 Nov, 2024

Ambuja Cements shares plummeted significantly on November 21, 2024, following bribery allegations against Gautam Adani. The stock saw substantial trading volume and a notable decline in market capitalization, reflecting broader market volatility and sector challenges.

Ambuja Cements Stock Sees Minor Decline - 19 Nov, 2024

Ambuja Cements shares fell 0.89% to Rs 555.20, with a total traded quantity of 30,746 shares. The stock's P/E ratio is 45.77, and the RSI is at 39.94, indicating potential oversold conditions. Promoters hold 67.57% stake.

Ambuja Cements Market Cap Increases by Rs 1,222 Crore - 18 Nov, 2024

Ambuja Cements' stock rose by 0.90% to Rs 549.40, boosting its market capitalization by Rs 1,222 crore to Rs 1,35,324 crore. The stock reflects stable investor demand amid infrastructure growth in India.

Ambuja Cements Pursues Major Stake in Orient Cement - 12 Nov, 2024

Ambuja Cements, led by Gautam Adani, has sought approval from the CCI to acquire a majority stake in Orient Cement for Rs 8,100 crore. The acquisition involves a two-stage process, starting with a 46.8% stake, potentially increasing to 72.8% through an open offer. The deal aims to enhance Ambuja's market position without raising competition concerns.

Ambuja Cements Pursues Major Stake in Orient Cement - 11 Nov, 2024

Ambuja Cements, led by Gautam Adani, has approached the CCI for approval to acquire a 46.80% stake in Orient Cement for Rs 8,100 crore, potentially increasing its stake to 72.8% through an open offer. The acquisition aims to enhance Adani Cement's capacity by 16.6 MTPA.

Ambuja Cements Faces Legal Relief Amid Financial Challenges - 10 Nov, 2024

The Delhi HC dismissed a ₹218 crore stamp duty order and ₹69 crore penalty against Ambuja Cements, providing relief. However, Q2 results showed a 42.5% profit decline, raising investor concerns about financial health.

Delhi High Court Quashes Stamp Duty Order Against Ambuja Cement - 08 Nov, 2024

The Delhi High Court has quashed a ₹218 crore stamp duty order against Ambuja Cement, ruling the notice was issued beyond the limitation period and affirming the merger was exempt from stamp duty.

Ambuja Cements Receives Buy Rating Amid Challenges - 30 Oct, 2024

Prabhudas Lilladher maintains a Buy rating on Ambuja Cements, revising the target price to Rs. 708. Despite short-term pricing challenges, strong volume growth and cost optimization strategies position the company for long-term success, with a projected 24% upside.

Ambuja Cements Reports Mixed Q2 Results and Growth Plans - 29 Oct, 2024

Ambuja Cements showcased strong sales volume growth in Q2 FY25 but reported a significant profit decline. The company aims to expand production capacity to 140 million tonnes by 2027-28, maintaining a solid cash position and exploring acquisitions.

Ambuja Cements Faces Profit Decline Amid Growth Prospects - 28 Oct, 2024

Ambuja Cements reported a significant decline in Q2FY25 net profit but anticipates growth driven by infrastructure demand and government initiatives like PMAY. The company achieved record revenue and volume growth, despite challenges in the first half of the fiscal year.

Ambuja Cements Acquires Stake in Orient Cement - 26 Oct, 2024

Ambuja Cements has signed a binding agreement to acquire a 46.8% stake in Orient Cement Ltd for Rs 8,100 crore, marking its third acquisition in a year.

Ambuja Cements Expands Capacity with New Acquisition - 24 Oct, 2024

Ambuja Cements has signed a binding agreement to acquire Orient Cement for Rs 8,100 crore, enhancing its capacity by 16.6 MTPA and aiming for 100 MTPA by FY25.

Ambuja Cements Acquires Stake in Orient Cement - 23 Oct, 2024

Ambuja Cements plans to acquire a 47% stake in Orient Cement for Rs 3,791 crore, aiming to strengthen its market position and increase capacity. The acquisition is expected to enhance Ambuja's limestone reserves and support its growth strategy, despite potential mid-term pricing pressures in the South Indian market.